Sogen Data · Datasets · 数据专题
骨肉瘤复发轴数据集锦
单细胞 · 空转 · bulk 转录组
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源单细胞
Human · Single-cell
-
01 GSE198896 对骨肉瘤复发和原发患者以及Ewing肉瘤复发和原发患者的外周血和肿瘤浸润免疫细胞进行单细胞RNA测序,同时纳入健康青少年供体的外周血单核细胞作为对照,比较不同疾病状态和复发状态下的免疫细胞转录特征差异。
设计对骨肉瘤复发和原发患者以及Ewing肉瘤复发和原发患者的外周血和肿瘤浸润免疫细胞进行单细胞RNA测序,同时纳入健康青少年供体的外周血单核细胞作为对照,比较不同疾病状态和复发状态下的免疫细胞转录特征差异。
摘要Ewing and osteosarcoma are bone sarcomas that occur predominantly in adolescents. In the setting of metastatic or recurrent disease, overall prognosis is poor. While immunotherapy is effective for some adult soft tissue sarcoma, limited success has been achieved with immunotherapy for pediatric bone sarcomas. To better understand antitumor immunity in Ewing and osteosarcoma patients, we performed single-cell RNAseq on peripheral blood and tumor infiltrating immune populations using 10X Genomics droplet-based approach. We also included peripheral blood from healthy adolescent blood donors as a comparator. Utilizing these transcriptional profiles, we characterized tumor infiltrating CD8+ T cells and myeloid cells and identified intercellular communication networks in both primary and recurrent disease.
-
02 GSE318840 对8例骨肉瘤患者冷冻肿瘤标本进行单细胞固定RNA测序,样本按治疗前(n=2)、化疗后(n=2)、复发(n=2)和肺转移(n=2)四个临床阶段分组。采用10x Genomics Chromium Next GEM Single Cell Fixed RNA Profiling (FLEX)技术,通过机械与酶解 dissociation 获取单细胞悬液,检测总RNA表达特征,比较不同临床阶段间细胞转录组差异。
设计对8例骨肉瘤患者冷冻肿瘤标本进行单细胞固定RNA测序,样本按治疗前(n=2)、化疗后(n=2)、复发(n=2)和肺转移(n=2)四个临床阶段分组。采用10x Genomics Chromium Next GEM Single Cell Fixed RNA Profiling (FLEX)技术,通过机械与酶解 dissociation 获取单细胞悬液,检测总RNA表达特征,比较不同临床阶段间细胞转录组差异。
摘要Osteosarcoma remains a profound clinical challenge, particularly for patients with metastatic or recurrent disease where survival rates have stagnated for decades. In this study, we present the first systematic application of Single-cell Fixed RNA Profiling (FLEX) to the osteosarcoma clinical spectrum. We profiled over 40,000 cells across treatment-naïve, post-chemotherapy, recurrent, and lung metastatic stages. By identifying the ADAMTS12/RNASE1/S100A4/PLVAP multi-cellular network, we move beyond simple cell-type identification toward an integrated understanding of how malignant cells and their microenvironment co-evolve. These findings offer a translational framework for improved risk stratification and the development of next-generation therapies designed to disrupt the interactive networks supporting metastatic osteosarcoma.
人源空转
Human · Spatial
-
01 GSE293065 本研究对26例骨肉瘤样本进行空间转录组分析,包括9例原发性骨肉瘤和17例复发样本(局部软组织复发、局部假体周围复发、肺转移、淋巴结转移、心脏转移)。采用10X Genomics Visium V1 FFPE协议,使用人类全转录组探针集,检测组织区域经病理学家根据H&E染色预选,5微米切片制备。主要比较原发与复发样本的表面蛋白基因表达及免疫细胞动态差异。
设计本研究对26例骨肉瘤样本进行空间转录组分析,包括9例原发性骨肉瘤和17例复发样本(局部软组织复发、局部假体周围复发、肺转移、淋巴结转移、心脏转移)。采用10X Genomics Visium V1 FFPE协议,使用人类全转录组探针集,检测组织区域经病理学家根据H&E染色预选,5微米切片制备。主要比较原发与复发样本的表面蛋白基因表达及免疫细胞动态差异。
摘要Osteosarcoma remains a highly aggressive malignancy with limited advancements in treatment efficacy and survival rates over the past four decades. Current therapeutic strategies fail in a significant proportion of patients, leading to metastatic relapse and poor prognosis. The substantial genomic instability and cellular plasticity of osteosarcoma contribute to its complex biology, necessitating innovative approaches for improved diagnosis and treatment. In this study, we applied spatial transcriptomics (ST) to 26 osteosarcoma samples, primary tumors and metastatic or local relapse samples. We described diverse differentiation phenotypes, ranging from mostly undifferentiated to metaphyseal-like organized highly differentiated phenotypes. Despite the phenotypic variability within and across samples, a comprehensive surfaceome analysis identified 306 cancer-specific membrane protein genes, among which nine formed a robust osteosarcoma-specific theranostic signature validated in multiple bulk RNAseq datasets. Additionally, spatial analysis of immune cell dynamics confirmed the systemic lymphoid cell exclusion and distinguished between cancer-excluded and -infiltrating myeloid populations. This identified three distinct populations along the osteoclastic lineage, with a systematic cancer-infiltration capacity. Cancer-infiltrating potential was also associated with type I interferon response and specific integrin-mediated adhesion mechanisms. This study provides a valuable resource to improve the understanding of osteosarcoma biology. We also suggest new clinically relevant targets in osteosarcoma, enabling the development of adapted and targeted treatment strategies for patients with the hope of improving clinical outcomes in the future.
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE237033 研究收集了7位患者在疾病进展过程中多个骨肉瘤样本,按原发、复发和转移阶段分组,进行RNA测序和影像质谱分析,比较不同阶段的转录组和表型特征。
设计研究收集了7位患者在疾病进展过程中多个骨肉瘤样本,按原发、复发和转移阶段分组,进行RNA测序和影像质谱分析,比较不同阶段的转录组和表型特征。
摘要Osteosarcoma is the most common primary bone sarcoma. About 50% of patients develop metastatic disease and their 5-year survival lingers at around 20-30%. T cell checkpoint blockade immunotherapies have revolutionized cancer treatment in the last decade, but their impact remains limited in osteosarcoma. In order to reveal potentially novel immunotherapeutic strategies for advanced osteosarcoma, we conducted an immunogenomic characterization of a unique sample set comprising multiple osteosarcoma samples from seven patients, collected throughout the progression of the disease. We performed RNA-sequencing and imaging mass cytometry analysis on those samples to reveal the immunological landscape during osteosarcoma progression. Transcriptional and phenotypical hallmarks of cytotoxic T cell-driven anti-cancer immunity were enriched in metastatic lesions as compared to primary tumors. In parallel, we found a pronounced increase in the expression of cancer testis antigens, particularly MAGEA-related antigens, in osteosarcoma metastases. Their overexpression in metastatic lesions was confirmed at protein level and positive expression of MAGEA3 in primary tumors showed a significant association with metastasis free survival. Importantly, we demonstrated the presentation of MAGE-derived peptides in three osteosarcoma cell lines. These findings indicate a concurrent augmentation of cytotoxic anti-tumor immune responses and expression of MAGEA antigens from primary to metastatic osteosarcoma. This observation warrants the exploration of MAGEA antigens as potential targets for immunotherapy in the treatment of advanced osteosarcoma.
-
02 GSE39057 对人类骨肉瘤的活检和切除样本对进行mRNA表达分析,比较每对样本的转录组差异,采用配对设计,样本来自不同年龄、性别及化疗方案的患者。
设计对人类骨肉瘤的活检和切除样本对进行mRNA表达分析,比较每对样本的转录组差异,采用配对设计,样本来自不同年龄、性别及化疗方案的患者。
摘要Osteosarcoma is a malignancy with variable outcomes that are not tightly aligned with chemotherapy response. Previous work has suggested a possible role for microRNAs (miRNAs) in determining the susceptibility of osteosarcomas to treatment but formal miRNA-based outcome models have not been reported. Formalin-fixed, paraffin-embedded (FFPE) specimens may be a unique approach for such studies in a rare malignancy. We used supervised principal components analysis and logistic regression to study survival and chemoresponse endpoints, and miRNA activity and gene set analysis algorithms to study miRNA regulatory networks using mRNA data. Our study also creates a paradigm for FFPE-based miRNA clinical biomarker research in rare tumors.
犬空转
Dog · Spatial
-
01 GSE295311 Pet dogs spontaneously develop many of the same tumor types as humans including osteosarcoma. Utilizing the canine patient model facilitates the study of novel therapeutics and biomarkers within the context of spontaneous carcinogenesis, inclusive of treatment resistance, metastatic progression and immune responses that mirror that observed in human cancers. Recent advances in spatial transcriptomics have improved our ability to utilize formalin-fixed paraffin-embedded tissues collected at canine autopsy. These techniques allow the canine model to be investigated alongside murine models to inform human cancer research. Herein we present the first application of the GeoMx Canine Cancer Atlas to outcome-linked samples from canine patients enrolled in an osteosarcoma clinical trial.
摘要Pet dogs spontaneously develop many of the same tumor types as humans including osteosarcoma. Utilizing the canine patient model facilitates the study of novel therapeutics and biomarkers within the context of spontaneous carcinogenesis, inclusive of treatment resistance, metastatic progression and immune responses that mirror that observed in human cancers. Recent advances in spatial transcriptomics have improved our ability to utilize formalin-fixed paraffin-embedded tissues collected at canine autopsy. These techniques allow the canine model to be investigated alongside murine models to inform human cancer research. Herein we present the first application of the GeoMx Canine Cancer Atlas to outcome-linked samples from canine patients enrolled in an osteosarcoma clinical trial.

课题合作 · 扫码加微信
bioinformaticsboy